Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study

被引:9
|
作者
Bai, Anying [1 ]
Xue, Peng [1 ,3 ]
Li, Qing [2 ]
Jiang, Yu [1 ,3 ]
Qiao, Youlin [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China
[2] Shenzhen Matern & Child Healthcare Hosp, Diag & Treatment Cerv Les Ctr, Shenzhen, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Dept Epidemiol & Biostat, Beijing 100730, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 13期
关键词
cervical cancer; cytology; HPV genotype; unnecessary referrals; PATHOLOGY SCREENING GUIDELINES; AMERICAN-CANCER-SOCIETY; HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; POSITIVE WOMEN; INFECTIONS; PREVENTION; TRIAGE; PREVALENCE; COLPOSCOPY;
D O I
10.1002/cam4.6109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) is a necessary cause of cervical cancer, and a tool more sensitive than cytology for the early screening of cervical precancers. The two most carcinogenic genotypes HPV 16/18 have been reported in the majority of studies. High-risk HPVs other than HPV 16/18 (non-16/18-hrHPVs) cause approximately a quarter of cervical cancers, and we aimed to analyze the genotype-specific prevalence, risk and diagnostic efficiency of non-16/18-hrHPVs in cervical carcinogenesis among Chinese cytology-negative women.Methods: A total of 7043 females who had abnormal cervical testing results from January 2018 to October 2021 were enrolled, among them 3091 were cytology-negative. Descriptive statistics was used to estimate the HPV genotype-specific prevalence, and multivariable logistic regression was used to estimate the genotype-specific non-16/18 hrHPVs risk of cervical carcinogenesis. The evaluation of diagnostic value among HPV genotypes included the possibility of predicting cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/CIN3+) and the diagnostic efficiency measured by increased referral rate and referral numbers of colposcopies per additional CIN2+/CIN3+ detected.Results: Among HPV-positive cytology-negative women, the five dominant genotypes for CIN2+/CIN3+ were HPV 31/33/35/52/58. HPV 52/58/33 had comparatively high sensitivity and specificity in predicting CIN2+/CIN3+, while the referral strategy of multiple HPV58 required 26 colposcopies to detect 1 CIN3+, compared with 14, 12, and 8 required by multiple HPV52, 31, and 33, respectively.Conclusions: HPV31/33/35/52/58 infections are significant risk factors for cervical lesions, and multiple HPV 31/33/52 infections should be included in the previously recommended HPV16/18 genotyping triage for colposcopy in China, as the benefits of disease prevention may outweigh the disadvantages of increasing requirements for colposcopy services.
引用
收藏
页码:14794 / 14805
页数:12
相关论文
共 50 条
  • [21] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    PLOS ONE, 2015, 10 (03):
  • [22] High Rates of High-Grade Cervical Dysplasia in High-Risk Young Women With Low-Grade Cervical Cytology
    Daily, Laura R.
    Erickson, Britt K.
    Pasko, Daniel N.
    Straughn, J. Michael
    Huh, Warner K.
    Leath, Charles A., III
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2018, 22 (03) : 207 - 211
  • [23] Clinical impact of age-specific distribution of combination patterns of cytology and high-risk HPV status on cervical intraepithelial neoplasia grade 2 or more
    Sakai, Mie
    Ohara, Tsutomu
    Suzuki, Haruka
    Kadomoto, Tatsuki
    Inayama, Yoshihide
    Shitanaka, Shimpei
    Sumitomo, Masahiro
    Matsumura, Noriomi
    Yamanoi, Koji
    ONCOLOGY LETTERS, 2023, 26 (03)
  • [24] Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single-center study in China
    Wang, Zhiling
    Liu, Ting
    Wang, Yunjian
    Gu, Ying
    Wang, Hui
    Liu, Jingkang
    Cui, Baoxia
    Yang, Xingsheng
    INFECTIOUS AGENTS AND CANCER, 2020, 15 (01)
  • [25] Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China
    Xu, Huihui
    Lin, Aifen
    Shao, Xiujuan
    Shi, Weiwu
    Zhang, Yang
    Yan, Weihua
    ONCOTARGET, 2016, 7 (50) : 83775 - 83783
  • [26] Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women
    Del Mistro, Annarosa
    Frayle, Helena
    Ferro, Antonio
    Callegaro, Susanna
    Del Sole, Annamaria
    Stomeo, Anna
    Cirillo, Emanuela
    Fedato, Chiara
    Pagni, Silvana
    Barzon, Luisa
    Zorzi, Manuel
    JOURNAL OF MEDICAL SCREENING, 2014, 21 (01) : 30 - 37
  • [27] A Retrospective Study of Cytology, High-Risk HPV, and Colposcopy Results of Vaginal Intraepithelial Neoplasia Patients
    Cong, Qing
    Song, Yu
    Wang, Qing
    Zhang, Hongwei
    Gao, Shujun
    Sui, Long
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [28] Older women testing positive for HPV16/18 on cervical screening and risk of high-grade cervical abnormality
    Roberts, Jennifer Margaret
    Machalek, Dorothy A.
    Butler, Bethan C.
    Crescini, Joanne
    Garland, Suzanne M.
    Farnsworth, Annabelle
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (08) : 1593 - 1600
  • [29] HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN
    McKenna, M.
    McMenamin, M.
    McDowell, A.
    CYTOPATHOLOGY, 2016, 27 (04) : 261 - 268
  • [30] Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China
    Tao, Xiang
    Austin, R. Marshall
    Yu, Ting
    Zhong, Fangfang
    Zhou, Xianrong
    Cong, Qing
    Sui, Long
    Zhao, Chengquan
    CANCER CYTOPATHOLOGY, 2022, 130 (04) : 248 - 258